Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Benzethonium is a synthetic quaternary ammonium salt with surfactant, antiseptic, and broad-spectrum antimicrobial properties. It is primarily used as a topical antimicrobial agent in first aid antiseptics for cleaning hands and minor cuts or scrapes. Benzethonium exhibits activity against bacteria, fungi, mold and viruses by disrupting the cytoplasmic and outer membrane lipid bilayers of microorganisms—its positively charged quaternary nitrogen associates with acidic membrane phospholipids while its hydrophobic tail interacts with the membrane core. This leads to solubilization of membranes and cell lysis. Benzethonium may also induce apoptosis in cancer cells via mitochondrial or rough endoplasmic reticulum dysregulation. It is found in various over-the-counter products such as mouthwashes and anti-itch ointments at concentrations of 0.1–0.2%, which are considered safe by the FDA[1][4][6].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on benzethonium.